InFlectis
is a France-based biotechnology company that researches and develops small molecule therapies for the treatment of neuromuscular diseases... Read moreInFlectis
is a France-based biotechnology company that researches and develops small molecule therapies for the treatment of neuromuscular diseases... Read more
News
Feb 06, 2025
citybuzz
InFlectis: Promising Results Emerge for Novel ALS Treatment IFB-088 in Phase 2a Clinical Study
Jan 31, 2024
centralcharts
Press Release: InFlectis : InFlectis BioScience Completes Enrollment of Its Phase 2 Trial of IFB-088 for the Treatment of Amyotrophic Lateral Sclerosis; Anticipates Initial Results Later This Year
Jan 03, 2024
BioSpace
InFlectis BioScience: InFlectis BioScience Awarded $943,000 Grant from the ALS Association to Advance Ongoing ALS Clinical Trial with the Support of IRCCS Carlo Besta Neurological Institute
Dec 19, 2022
centralcharts
Press Release: InFlectis BioScience : InFlectis BioScience Doses First Patient with IFB-088 in a Phase 2 Clinical Trial for the Treatment of Amyotrophic Lateral Sclerosis
Mar 28, 2022
NewsFile
Press Release: InFlectis BioScience : InFlectis BioScience Granted Orphan Drug Designation for IFB-088 (icerguastat), a Clinical Stage Treatment for Amyotrophic Lateral Sclerosis
Jan 10, 2022
MarketScreener
InFlectis BioScience: InFlectis BioScience Receives Approval from French Regulatory Authority to Conduct a Phase 2 Clinical Trial for IFB-088 (Icerguastat) for the Treatment of Amyotrophic Lateral Sclerosis
Oct 04, 2021
FinanzNachrichten
InFlectis BioScience: Reportable, Inc.: InFlectis BioScience Expands Leadership Team with Three Experienced International Appointments: Mark Pykett Is Appointed Chairman, Batrice Lejeune Is Appointed Chief Regulatory Officer, and Prof. Brian Popko Joins Scientific Advisory Bo
Jun 22, 2021
MarketScreener
InFlectis BioScience: InFlectis BioScience Licenses Rights to a Potential New Class of Therapies for Demyelinating Diseases from The University of Chicago
Oct 16, 2018
BioPortfolio
InFlectis BioScience: InFlectis BioScience Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13082018 Prices from USD $250
Aug 22, 2018
BioPortfolio
InFlectis BioScience: InFlectis BioScience Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 23042018 Prices from USD $250
InFlectis Competitors
1
2
3
4
5
6
7
8
9
10